<?xml version="1.0" encoding="UTF-8"?>
<p id="p0255">Presently, there is no vaccination nor antiviral therapy for the ECoV, early induction of antiviral drugs remains the backbone management, neurologically the therapeutic dosages of LMWH are linked high frequency of thrombotic complexities while methylprednisolone is associated with myopathy. Future inter-continental studies, exploring prognosis, outcomes and applying neuroimaging techniques expected to explore the SARS-CoV-2 neurological implications fully.</p>
